• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Obstetrics

Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer

bySimon Pan, MDandAlex Chan
March 20, 2025
in Obstetrics, Oncology
Reading Time: 2 mins read
Everyday medicines collage: an older woman in round glasses behind plain tablets and capsules on a napkin and a water glass
Share on FacebookShare on TwitterShare on LinkedIn

1. In patients with advanced or recurrent endometrial cancer (EC) with previous exposure to carboplatin and paclitaxel (PT), lenvatinib plus pembrolizumab was not associated with improved survival compared with re-challenge PT. 

Evidence Rating Level: 2 (Good)

Currently, PT three times per week remains the first-line therapy for recurrent or advanced endometrial cancer. However, outcomes associated with second-line therapy for recurrent or advanced EC have been poor, necessitating further research to identify novel strategies for second-line management. This retrospective study therefore sought to investigate the use of lenvatinib plus pembrolizumab or re-challenge PT in patients with PT-pretreated advanced or recurrent EC. Propensity score matching was conducted to identify 334 pairs of individuals with PT-pretreated advanced or recurrent EC and who received one of re-challenge PT (median age, 65.5 years) or lenvatinib plus pembrolizumab (median age, 66.8 years) from the TriNetX Research Network in the United States. 378 individuals receiving doxorubicin were also included. After propensity score matching, there was no significant difference in the median overall survival (OS) rate between those receiving re-challenge PT and lenvatinib plus pembrolizumab (median OS: 19.5 vs. 17.1 months, p = 0.53; aHR: 0.88, 95% CI 0.62–1.24). After propensity score matching, lenvatinib plus pembrolizumab was associated with a significantly greater median OS compared to doxorubicin (median OS: 16.7 vs. 9.1 months, p < 0.001; aHR: 0.44, 95% CI 0.32–0.59). Overall, this study found that among patients with PT-pretreated advanced or recurrent EC, lenvatinib plus pembrolizumab was not associated with improved survival compared with re-challenge PT.

Click to read the study in BMC Medicine

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort

Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation

Tags: endometrial cancergynecologyobstetricsoncologySurgery
Previous Post

Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy

Next Post

Safer Births Bundle of Care reduces perinatal mortality in Tanzania

RelatedReports

Comparison of two types of bariatric surgery: a sleeve gastrectomy represented by a drawn stomach outline and a gastric band represented by a stomach with a band.
Chronic Disease

Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort

November 18, 2026
Mitral valve prolapse collage of an engraved heart with a parachute-like valve, a stethoscope and a calm woman
Cardiology

Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation

October 31, 2026
The image illustrates antibodies and a pill, representing immunotherapy and steroid treatments in oncology, with visual elements suggesting timing of administration.
2MM Trial Briefs

Sacituzumab tirumotecan improved progression-free and overall survival versus chemotherapy in previously treated endometrial cancer

October 29, 2026
Two pieces of fabric showing stitching techniques with surgical tools in the foreground, indicating procedures for hernia repair.
Gastroenterology

Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol

October 20, 2026
Next Post
Pregnancy care collage: a drawing of a head-down fetus in the uterus, a fetal listening horn and knitted baby booties

Safer Births Bundle of Care reduces perinatal mortality in Tanzania

Brain bleed care collage: a smiling older woman in a knit shawl, a forked artery with a small round bulge and a teacup

Liberal transfusion strategy not beneficial in treating aneurysmal subarachnoid hemorrhage

Bloodstream infection antibiotics collage: a cutaway blood vessel with blue rod-shaped bacteria inside and a blank wristband

Seven days of antibiotic treatment non-inferior to 14 days for bloodstream infections

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults
  • Gait analysis predicts health, sleep, and medication use across 18 body systems
  • Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.